Latest Breaking News On - Xlife sciences - Page 2 : comparemela.com

Xlife Sciences AG Publishes 2023 Annual Report

Xlife Sciences AG / Key word: Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The.

Abu dhabiAbuz abyUnited arab emiratesUnited statesOliverr baumannSynimmune gmbEuropean patent officeXlife sciencesAxenoll life sciencesLife sciences hubBusiness developmentDepartment of health abu dhabiXlife groupOperational progressSynimmune gmbhProstate carcinoma

Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland

Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Oliverr baumannXlife sciencesProstate carcinomaEuropean economic areaSwiss open telekom cloudShareholders meetingYear report

Department of Health – Abu Dhabi inks strategic partnership with Masdar City, Xlife Sciences, and Thermo Fisher Scientific

Department of Health – Abu Dhabi inks strategic partnership with Masdar City, Xlife Sciences, and Thermo Fisher Scientific
zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.

Abu dhabiAbuz abyUnited arab emiratesMohamed al breikiAhmad baghoumUrmi prasad richardsonSarah chahineAsma ibrahim al mannaeiNoura khamis al ghaithiOliverr baumannDepartment of healthArab healthXlife sciencesThermo fisherInnovation centre at doOliverr baumann xlife sciences

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline

Xlife Sciences AG / Key word: Mergers & Acquisitions/Takeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29-Dec-2023 / 17:45 CET/CEST Release of an ad hoc.

Christoph antzOliverr baumannSynimmune gmbXlife sciencesSynimmune gmbhAcute myeloid leukemiaAcute myeloidShareholders meetingYear report

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten

Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to

Synimmune gmbChristoph antzOliverr baumannXlife sciencesSynimmune gmbhAcute myeloid leukemiaAcute myeloidShareholders meetingYear report